PET in lung cancer.

[1]  M. Mandelkern,et al.  Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. , 1996, American journal of respiratory and critical care medicine.

[2]  P C Goodman,et al.  Staging non-small cell lung cancer with whole-body PET. , 1999, Radiology.

[3]  V. Lowe,et al.  Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. , 1995, Chest.

[4]  H. Tonami,et al.  Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  David J. Yang,et al.  Detecting recurrent or residual lung cancer with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[7]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[8]  N. Gupta,et al.  Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. , 1998, Chest.

[9]  D. Slosman,et al.  Satellite PET and lung cancer: a prospective study in surgical patients , 1993, Nuclear medicine communications.

[10]  L. Kostakoglu,et al.  Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. , 2000, Seminars in ultrasound, CT, and MR.

[11]  N. Gupta,et al.  Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose , 1994 .

[12]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[13]  Scott T. Grafton,et al.  PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.

[14]  M Fujita,et al.  Prevalence of air bronchograms in small peripheral carcinomas of the lung on thin-section CT: comparison with benign tumors. , 1991, AJR. American journal of roentgenology.

[15]  E. Davis,et al.  The Solitary Pulmonary Nodule , 1965 .

[16]  V J Lowe,et al.  Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). , 1995, The Journal of thoracic and cardiovascular surgery.

[17]  R. Coleman,et al.  Detection of deep venous thrombosis by magnetic resonance imaging. , 1993, Chest.

[18]  U Ruotsalainen,et al.  Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  V. Lowe,et al.  Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. , 1996, American Journal of Clinical Oncology.

[20]  A. Alavi,et al.  Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Shepherd,et al.  Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. , 1998, The Annals of thoracic surgery.

[22]  T. Turkington,et al.  FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET. , 1999, Radiology.

[23]  M. Sasaki,et al.  A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma , 1996, Annals of nuclear medicine.

[24]  J. Reed,et al.  Mediastinal staging of non-small-cell lung cancer with positron emission tomography. , 1995, American journal of respiratory and critical care medicine.

[25]  K. Mori,et al.  Small nodular lesions in the lung periphery: new approach to diagnosis with CT. , 1990, Radiology.

[26]  E. Buonocore,et al.  Characterization of Chest Masses by FDG Positron Emission Tomography , 1995, Clinical nuclear medicine.

[27]  S. Swensen,et al.  Approach to the solitary pulmonary nodule. , 1993, Mayo Clinic proceedings.

[28]  B Ghaye,et al.  Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. , 1999, The European respiratory journal.

[29]  R. Hustinx,et al.  Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. , 1997, The European respiratory journal.

[30]  S. A. Khonsary,et al.  PET-FDG SCANNING IN PULMONARY MASS LESION , 1993 .

[31]  J. Gurney,et al.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. , 1993, Radiology.

[32]  S S Gambhir,et al.  Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  R L Wahl,et al.  Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.

[34]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[35]  R. Coleman,et al.  Pulmonary abnormalities and PET data analysis: a retrospective study. , 1997, Radiology.

[36]  Clinical PET: are we ready? , 1997 .

[37]  R Iwata,et al.  Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  T. Tong,et al.  Cancer statistics, 1992 , 1992, CA: a cancer journal for clinicians.

[39]  E. Rosenow,et al.  Evaluation and management of solitary and multiple pulmonary nodules. , 1992, Clinics in chest medicine.

[40]  D Delbeke,et al.  Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Y. Nishiwaki,et al.  Prognostic factors in clinical stage I non-small cell lung cancer. , 1999, The Annals of thoracic surgery.

[42]  J M Hoffman,et al.  Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  V. Chuang,et al.  Solitary cavities of the lung: diagnostic implications of cavity wall thickness. , 1980, AJR. American journal of roentgenology.

[44]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  N. Müller,et al.  Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.

[46]  I. Magrath,et al.  Cancer in developing countries: opportunity and challenge. , 1993, Journal of the National Cancer Institute.

[47]  P. Valk,et al.  Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.

[48]  R. Coleman,et al.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.

[49]  M. Mack,et al.  Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. , 1993, The Annals of thoracic surgery.

[50]  D K Owens,et al.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.

[51]  Coleman Re.  Camera-based PET: the best is yet to come. , 1997 .

[52]  N. Gupta,et al.  PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. , 1995, Chest.

[53]  J M Hoffman,et al.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[54]  B J McNeil,et al.  CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. , 1991, Radiology.